Epidermolysis Bullosa Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Dose-ranging Study of Dentoxol ® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa.
Conditions: Epidermolysis Bullosa; Oral Ulcer Intervention: Combination Product: Dentoxol mouthrinse dosages Sponsors: University of Chile; Fundación Debra Chile Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2022 Category: Research Source Type: clinical trials
